Avalo Therapeutics, Inc. - COMMON STOCK (AVTX)
CUSIP: 05338F306
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 22,853,024
- Total 13F shares
- 15,317,685
- Share change
- +7,474,645
- Total reported value
- $194,685,792
- Put/Call ratio
- 46%
- Price per share
- $12.71
- Number of holders
- 65
- Value change
- +$95,069,684
- Number of buys
- 47
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 05338F306?
CUSIP 05338F306 identifies AVTX - Avalo Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05338F306:
Top shareholders of AVTX - Avalo Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
9.4%
|
1,235,000
|
$15,696,850 | +$4,257,850 | 30 Sep 2025 | |
| Ikarian Capital, LLC |
13D/G
13F
|
Company |
3.8%
|
711,967
|
$9,049,101 | -$6,100,673 | 30 Sep 2025 | |
| BVF INC/IL |
13F
|
Company |
4.5%
|
1,028,049
|
$5,129,965 | — | 30 Jun 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
4.2%
|
967,000
|
$4,825,330 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
4.1%
|
932,973
|
$4,655,535 | — | 30 Jun 2025 | |
| Patrick J. Crutcher |
13D/G
|
— |
4.2%
|
549,467
|
$3,593,514 | $0 | 06 Aug 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
2.7%
|
607,872
|
$3,033,281 | — | 30 Jun 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
2.5%
|
567,103
|
$2,829,844 | — | 30 Jun 2025 | |
| Commodore Capital LP |
13F
|
Company |
2.1%
|
483,000
|
$2,410,170 | — | 30 Jun 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
2.1%
|
483,000
|
$2,410,170 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.8%
|
406,571
|
$2,028,790 | — | 30 Jun 2025 | |
| RWA WEALTH PARTNERS, LLC |
13F
|
Company |
1.1%
|
261,016
|
$1,302,470 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.73%
|
166,941
|
$833,036 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.68%
|
155,899
|
$777,936 | — | 30 Jun 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.68%
|
154,972
|
$773,310 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.61%
|
139,667
|
$696,938 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
110,460
|
$551,613 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.46%
|
104,730
|
$522,603 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.37%
|
83,724
|
$417,783 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
765,828
|
$397,771 | — | 26 Jun 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.32%
|
72,173
|
$360,143 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.1%
|
22,673
|
$113,138 | — | 30 Jun 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.09%
|
20,613
|
$102,859 | — | 30 Jun 2025 | |
| June Sherie Almenoff |
3/4/5
|
Director |
—
mixed-class rows
|
30,600
mixed-class rows
|
$88,830 | — | 17 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.06%
|
12,889
|
$64,316 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
11,321
|
$56,492 | — | 30 Jun 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.05%
|
10,976
|
$54,770 | — | 30 Jun 2025 | |
| Allostery Investments LP |
13F
|
Company |
0.04%
|
9,000
|
$44,910 | — | 30 Jun 2025 | |
| James Archie Harrell Jr. |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
36,766
|
$19,096 | — | 10 Dec 2021 | |
| H. Jeffrey Wilkins |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
33,373
|
$17,334 | — | 10 Dec 2021 | |
| Schond L. Greenway |
3/4/5
|
CFO |
—
class O/S missing
|
3,883
|
$2,017 | — | 10 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
74
|
$369 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
22
|
$110 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
10
|
$50 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
5
|
$25 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2
|
$8 | — | 30 Jun 2025 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
1
|
$5 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
1
|
$5 | — | 30 Jun 2025 | |
| Key FInancial Inc |
13F
|
Company |
0%
|
1
|
$5 | — | 30 Jun 2025 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
1
|
$5 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
1
|
$5 | — | 30 Jun 2025 | |
| Stephen Smolinski |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
400,000
|
— | — | 04 Jan 2022 | |
| Michael F. Cola |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
78,116
|
— | — | 01 Oct 2021 | |
| Sol J. Barer |
3/4/5
|
Director |
—
class O/S missing
|
40,000
|
— | — | 15 Jun 2021 | |
| Michael Thomas Heffernan |
3/4/5
|
Director |
—
class O/S missing
|
29,500
|
— | — | 17 Jun 2025 | |
| Joseph M. Miller |
3/4/5
|
Director |
—
class O/S missing
|
20,239
|
— | — | 31 Mar 2022 | |
| Suzanne Louise Bruhn |
3/4/5
|
Director |
—
class O/S missing
|
5,204
|
— | — | 10 Nov 2021 | |
| Phil Gutry |
3/4/5
|
Director |
—
class O/S missing
|
4,718
|
— | — | 01 Dec 2021 | |
| Magnus Persson |
3/4/5
|
Director |
—
class O/S missing
|
3,334
|
— | — | 20 Dec 2023 |
Institutional Holders of Avalo Therapeutics, Inc. - COMMON STOCK (AVTX) as of Q3 2025
As of 30 Sep 2025,
Avalo Therapeutics, Inc. - COMMON STOCK (AVTX) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,317,685 shares.
The largest 10 holders included
BVF INC/IL, ORBIMED ADVISORS LLC, Nantahala Capital Management, LLC, Point72 Asset Management, L.P., Affinity Asset Advisors, LLC, Caligan Partners LP, Balyasny Asset Management L.P., SILVERARC CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and RA CAPITAL MANAGEMENT, L.P..
This page lists
65
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
35
Q3 2025 holders
65
Holder diff
30
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.